Vignal-ClermoH C, Yu-Wai-Man P, Newman NJ, Carelli V, et al. Safety of lenadogene nolparvovec gene therapy over 5 years in 189 patients with Leber hereditary optic neuropathy. Am J Ophthalmol 2022 Dec 7:S0002-9394(22)00464.
PMID: 36496192